Sun Pharma to raise stake in US-based Pharmazz to 22.7%
Sun Pharma will invest up to $25 million in US-based Pharmazz Inc, raising its stake to 22.7%
Sun Pharma will invest up to $25 million in US-based Pharmazz Inc, raising its stake to 22.7%
Planned acquisition will strengthen the presence of Merck Healthcare in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide
Subscribe To Our Newsletter & Stay Updated